Harvest Technology Group Raises A$6.5 Million Placement to Accelerate Defence Growth
Harvest Technology Group secures a A$6.5 million two-tranche placement to fund its defence strategy, expand Nodestream, and strengthen its balance sheet ahead of key growth initiatives.
- Two-tranche placement raises A$6.5 million
- Tranche 2 subject to shareholder approval in July
- Funds to support defence strategy and Nodestream expansion
- Lead Manager Alpine Capital to receive fees and options
- Placement priced at A$0.01 per share, near last close
Placement Boosts Defence Strategy Funding
Harvest Technology Group (ASX:HTG) has secured firm commitments for a A$6.5 million placement designed to fuel its next phase of growth in global defence and autonomous systems. The raise is split into two tranches: an unconditional A$3 million tranche closing early June, and a conditional A$3.5 million tranche pending shareholder approval at a July general meeting. The placement price of A$0.01 per share matches the last closing price and represents a 9.8% discount to the 15-day volume weighted average price, signalling a fair value approach to institutional and sophisticated investors.
Executive Chair Jeff Sengelman highlighted the placement’s role in bolstering the company’s balance sheet and advancing its Go-to-Market Defence Strategy. This includes compliance and readiness initiatives, alongside the expansion of the company’s flagship Nodestream platform, which has been gaining traction in defence circles. The company has been actively pivoting towards defence, with Nodestream’s bandwidth-efficient remote operations technology validated through recent NATO and US defence engagements, underpinning this capital raise’s strategic rationale Nodestream platform validation and defence strategy progress.
Use of Funds Focused on Defence and Operational Expansion
The funds will be deployed across several priorities: accelerating the defence market rollout, enhancing defence readiness and compliance, expanding Nodestream’s capabilities and reach, and supporting general corporate working capital. This aligns with Harvest’s broader strategic shift towards defence and autonomous systems, a pivot that has been accompanied by leadership changes and a sharpened market focus earlier this year. The raise offers a financial runway to capitalise on the momentum from recent contract wins and technical validations of Nodestream’s suitability for bandwidth-constrained defence environments.
Alpine Capital is acting as Lead Manager and will receive a 6% cash fee plus up to 120 million unlisted options exercisable at A$0.02 each, subject to shareholder approval. These options have a two-year expiry and are non-transferable, providing Alpine with long-term incentive aligned with Harvest’s share price performance post-placement.
Shareholder Approval and Dilution Considerations
While Tranche 1 proceeds will be received imminently, the release of Tranche 2 funds hinges on shareholder approval expected in July. This introduces some uncertainty about the full capital injection but is a common mechanism to manage dilution and regulatory compliance. The placement will issue a total of 650 million new shares at A$0.01, which will dilute existing shareholders but strengthen the company’s financial position to pursue its strategic objectives.
Harvest’s recent financials showed a widening loss amid revenue volatility, but the company has been actively securing funding and partnerships to stabilise its position. This placement builds on previous capital raises and strategic moves, including a $1.632 million placement earlier this year and ongoing efforts to validate and commercialise Nodestream in defence markets funding rounds and leadership shifts.
Bottom Line?
The placement equips Harvest with fresh capital to deepen its defence market penetration, but shareholder approval for the second tranche and execution of its strategy remain key hurdles.
Questions in the middle?
- Will shareholder approval for Tranche 2 materialise as expected in July?
- How quickly can Harvest translate Nodestream validations into commercial contracts?
- What impact will the placement dilution have on existing shareholders’ confidence?